Clinical Utility of the Trail-Making Test as a Predictor of Driving Performance in Older Adults

• Autores: George D. Papandonatos, Brian R. Ott, Jennifer D. Davis, Peggy P. Barco, David B. Carr
• Localización: Journal of the American Geriatrics Society, ISSN 0002-8614, Vol. 63, Nº. 11, 2015, págs. 2358-2364
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • Objectives To assess the clinical utility of the Trail-Making Tests (TMTs) as screens for impaired road-test performance.

    Design Secondary analyses of three data sets from previously published studies of impaired driving in older adults using comparable road test designs and outcome measures.

    Setting Two academic driving specialty clinics.

    Participants Older drivers (N = 392; 303 with cognitive impairment, 89 controls) from Rhode Island and Missouri.

    Measurements Standard operating characteristics were evaluated for the TMT Part A (TMT-A) and Part B (TMT-B), as well as optimal upper and lower test cut-points that could be useful in defining groups of drivers with indeterminate likelihood of impaired driving who would most benefit from further screening or on-road testing.

    Results Discrimination remained high (>70%) when cut-points for the TMTs derived from Rhode Island data were applied to Missouri data, but calibration was poor (all P < .01). TMT-A provided the best utility for determining a range of scores (68–90 seconds) for which additional road testing would be indicated in general practice settings. A high frequency of cognitively impaired participants unable to perform the TMT-B test within the allotted time limited the utility of the test (>25%). Mere inability to complete the test in a reasonable time frame (e.g., TMT-A > 48 seconds or TMT-B > 108 seconds) may still be a useful tool in separating unsafe from safe or marginal drivers in such samples.

    Conclusion The TMTs (particularly TMT-A) may be useful as screens for driving impairment in older drivers in general practice settings, where most people are still safe drivers, but more-precise screening measures need to be analyzed critically in a variety of clinical settings for testing cognitively impaired older drivers.